Correction: Preventive Pharmacovigilance: timely and precise prevention of adverse events through person-level patient screening and dose-level product surveillance.

Yu, Yihua Bruce; Briggs, Katharine T; Taraban, Marc B

Yu, Yihua Bruce; Briggs, Katharine T; Taraban, Marc B.

Afiliação

Yu YB; Bio and Nano-Technology Center, University of Maryland School of Pharmacy, 20 North Penn Street, Baltimore, MD, 21201, USA. byu@rx.umaryland.edu.
Briggs KT; Institute for Bioscience and Biotechnology Research, 9600 Gudelsky Drive, Rockville, MD, 20850, USA. byu@rx.umaryland.edu.
Taraban MB; Bio and Nano-Technology Center, University of Maryland School of Pharmacy, 20 North Penn Street, Baltimore, MD, 21201, USA.

Pharm Res ; 40(9): 2107, 2023 Sep.

Article em En | MEDLINE | ID: mdl-37561324

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Pharm Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google